Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasm, Residual 2Leukemia 2Burkitt Lymphoma 2Myasthenia Gravis 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Graft vs Host Disease 1

Interventions

telitacicept 3rozanolixizumab 3talquetamab 1ravulizumab 1efgartigimod alfa 1blinatumomab 1Therapeutics 1Pyridostigmine Bromide 1Psychodrama 1Prednisone 1Population Groups 1Art Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Myasthenia Gravis × blinatumomab × Clear all
NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting
2 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡